Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.1660+0.0040 (+2.47%)
At close: 04:33PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 49.37M
Enterprise value 46.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)20.15
Price/book (mrq)9.33
Enterprise value/revenue 19.00
Enterprise value/EBITDA -7.55

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-46.89%
S&P500 52-week change 316.48%
52-week high 30.3500
52-week low 30.1260
50-day moving average 30.1763
200-day moving average 30.2192

Share statistics

Avg vol (3-month) 31.25M
Avg vol (10-day) 3186.61k
Shares outstanding 5265.45M
Implied shares outstanding 6N/A
Float 8140.99M
% held by insiders 148.81%
% held by institutions 13.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -281.92%
Operating margin (ttm)-257.63%

Management effectiveness

Return on assets (ttm)-25.03%
Return on equity (ttm)-93.94%

Income statement

Revenue (ttm)2.68M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-89.90%
Gross profit (ttm)3.75M
EBITDA -5.99M
Net income avi to common (ttm)-7.55M
Diluted EPS (ttm)-0.0290
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.67M
Total cash per share (mrq)0.03
Total debt (mrq)4.78M
Total debt/equity (mrq)90.28
Current ratio (mrq)1.69
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-1.86M
Levered free cash flow (ttm)4.56M